Philadelphia College of Osteopathic Medicine

DigitalCommons@PCOM
PCOM Scholarly Papers
9-1-2021

Addressing and Inspiring Vaccine Confidence in Black,
Indigenous, and People of Color During the Coronavirus Disease
2019 Pandemic
Jasmine R Marcelin
Talia H Swartz
Fidelia Bernice
Vladimir Berthaud
Robbie Christian

See next page for additional authors

Follow this and additional works at: https://digitalcommons.pcom.edu/scholarly_papers
Part of the Medicine and Health Sciences Commons

Recommended Citation
Marcelin, Jasmine R; Swartz, Talia H; Bernice, Fidelia; Berthaud, Vladimir; Christian, Robbie; da Costa,
Christopher; Fadul, Nada; Floris-Moore, Michelle; Hlatshwayo, Matifadza; Johansson, Patrik; Kullar, Ravina;
Manning, Kimberly; McGee, Edo-abasi U.; Medlin, Christopher; Piggott, Damani A; Syed, Uzma; Snowden,
Jessica; Tan, Tina; and Abdul-Mutakabbir, Jacinda C, "Addressing and Inspiring Vaccine Confidence in
Black, Indigenous, and People of Color During the Coronavirus Disease 2019 Pandemic" (2021). PCOM
Scholarly Papers. 2122.
https://digitalcommons.pcom.edu/scholarly_papers/2122

This Article is brought to you for free and open access by DigitalCommons@PCOM. It has been accepted for
inclusion in PCOM Scholarly Papers by an authorized administrator of DigitalCommons@PCOM. For more
information, please contact library@pcom.edu.

Authors
Jasmine R Marcelin, Talia H Swartz, Fidelia Bernice, Vladimir Berthaud, Robbie Christian, Christopher da
Costa, Nada Fadul, Michelle Floris-Moore, Matifadza Hlatshwayo, Patrik Johansson, Ravina Kullar,
Kimberly Manning, Edo-abasi U. McGee, Christopher Medlin, Damani A Piggott, Uzma Syed, Jessica
Snowden, Tina Tan, and Jacinda C Abdul-Mutakabbir

This article is available at DigitalCommons@PCOM: https://digitalcommons.pcom.edu/scholarly_papers/2122

Open Forum Infectious Diseases
INVITED ARTICLE

Jasmine R. Marcelin,1, Talia H. Swartz,2 Fidelia Bernice,3 Vladimir Berthaud,4, Robbie Christian,5 Christopher da Costa,6 Nada Fadul,1
Michelle Floris-Moore,7 Matifadza Hlatshwayo,8 Patrik Johansson,9 Ravina Kullar,10 Kimberly Manning,11 Edoabasi U. McGee,12, Christopher Medlin,13
Damani A. Piggott,14 Uzma Syed,15 Jessica Snowden,16 Tina Tan,17 and Jacinda C. Abdul-Mutakabbir18; on behalf of the Infectious Diseases Society of
America (IDSA) Inclusion, Diversity, Access, and Equity Taskforce, George Counts Interest Group, and Society of Infectious Diseases Pharmacists (SIDP)
Diversity, Equity and Inclusion Taskforce
1

Division of Infectious Diseases, University of Nebraska Medical Center, Omaha Nebraska, USA, 2Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York,
USA, 3Department of Pharmacy, University of Maryland Medical Center, Baltimore, Maryland, USA, 4Division of Infectious Diseases, Meharry Medical College, Nashville, Tennessee, USA, 5Our
Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, USA, 6The Coalition for Epidemic Preparedness Innovations, Washington, District of Columbia, USA, 7Division of Infectious
Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA, 8Division of Infectious Diseases, John Cochrane VA Medical Center, St. Louis, Missouri, USA,
9
Department of Medical Education and Clinical Sciences, Washington State University, Seattle, Washington, USA, 10Expert Stewardship Inc., Newport Beach, California, USA, 11Division of General
Medicine, Emory University School of Medicine, Atlanta, Georgia, USA, 12Philadelphia College of Osteopathic Medicine, School of Pharmacy, Suwanee, Georgia, USA, 13University of Texas at El
Paso School of Pharmacy, El Paso, Texas, USA, 14Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, 15South Shore Infectious Disease &
Travel Medicine Consultants, P.C., Bay Shore, New York, USA, 16Division of Pediatric Infectious Disease, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA, 17Northwestern
University Feinberg School of Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA, 18Department of Pharmacy Practice, Loma Linda University School of
Pharmacy, Loma Linda, California, USA

During the coronavirus disease 2019 (COVID-19) pandemic, we have witnessed profound health inequities suffered by Black,
Indigenous, and People of Color (BIPOC). These manifested as differential access to testing early in the pandemic, rates of severe
disease and death 2–3 times higher than white Americans, and, now, significantly lower vaccine uptake compared with their share
of the population affected by COVID-19. This article explores the impact of these COVID-19 inequities (and the underlying cause,
structural racism) on vaccine acceptance in BIPOC populations, ways to establish trustworthiness of healthcare institutions, increase
vaccine access for BIPOC communities, and inspire confidence in COVID-19 vaccines.
Keywords. Black, Indigenous, People of Color (BIPOC); COVID-19; structural racism; vaccine confidence.
The disproportionate coronavirus disease 2019 (COVID19) mortality among Black, Indigenous, and People of color
(BIPOC) communities is driven by inequities created by structural racism, including higher poverty rates, lower wage (essential worker) employment, and crowded living situations.
Inequitable distribution of these social determinants of health
influence risk factors for comorbidities, access to care, and delivery of care to different racial/ethnic groups [1–5]. Although
the COVID-19 pandemic has amplified these racial and ethnic
inequities, it has also highlighted the historical and current
factors contributing to distrust of healthcare institutions by
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BIPOC communities. This legacy includes a history of involuntary medical treatment and experimentation, including the
sustained ethical breach of 1932 US Public Health Servicefunded study of untreated syphilis in Black men at the Tuskegee
Institute, in which penicillin was intentionally withheld from
Black study participants without their knowledge for decades
after it was known to be an effective therapy for syphilis [6]. It
also includes a history of forced sterilization practices exerted
on women in Indigenous communities without informed consent at the hands of Indian Health Services (IHS) physicians
[7]. Furthermore, American Indian/Alaska Native (AI/AN)
communities are familiar with the devastating impacts of infectious diseases on their communities, having experienced significant population reduction after introduction of diseases such
as smallpox, measles, and influenza by European colonizers
[8]. According to Desi Rodriguez-Lonebear, a social demographer at the University of Arizona and citizen of the Northern
Cheyenne tribe in Montana, “More than any other population
in the country, the shared experience of surviving a pandemic is
in our blood, it’s not historic, it’s current for American Indians,
it’s our reality. We took it seriously because we had to” [9].
A further long documented history of segregated and substandard healthcare delivery has left a foundation of deep
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Addressing and Inspiring Vaccine Confidence in Black,
Indigenous, and People of Color During the Coronavirus
Disease 2019 Pandemic

CORONAVIRUS DISEASE 2019 AND BLACK,
INDIGENOUS AND PEOPLE OF COLOR
COMMUNITIES

The COVID-19 pandemic has resulted in more than 170 million
infections and 3.5 million deaths worldwide [29]. The United
States accounts for approximately one fifth of the global burden,
2 • ofid • Marcelin et al

with more than 33 million infections and almost 600 000 deaths
as of June 1, 2021 [29]. The transmission and disease severity
trends have highlighted key disparities in BIPOC communities,
which have been overrepresented in COVID-19 infections, hospitalizations, and deaths [30–32]. Social determinants of health
underlie the disparate impact of COVID-19 on BIPOC communities. These social determinants arise from long-standing
systemic racism and health inequity, including disparities in
healthcare access, employment and work conditions, transportation, incarceration, and housing circumstances [30–32].
These factors increase the risk of transmission and disproportionately high rates of preexisting comorbid conditions that
increase the risk of COVID-19 disease severity.
The high burden of COVID-19 disease and COVID-19related mortality in these populations makes the distribution
and uptake of critical preventative tools such as COVID-19
vaccines in BIPOC communities even more critical. Vaccine
development efforts have included representation of BIPOC individuals in clinical trials, and there is guidance for equitable
vaccine delivery and prioritizing populations at the highest
risk [33]. However, there may be barriers to equitable vaccine
uptake in BIPOC communities, including higher uninsurance
rates and concerns about cost, less access to care, vaccine appointments conflicting with other commitments, transportation barriers, and others [34]. Accordingly, across the country,
the proportion of BIPOC individuals being vaccinated lags behind their share of the US population, and their share of the
population affected by COVID-19 [28, 35], with the exception
of AI/AN individuals, who have higher vaccination rates relative to other racial groups [36].
In addition, many individuals from BIPOC communities
have expressed reluctance or barriers to receiving the available
vaccines [37], with several national surveys reporting rates of
reluctance ranging from 25% to 50% [38–41]. Among those expressing reluctance, reasons included safety concerns related to
lack of sufficient time for vaccine development, a lack of trust
in or having doubts about the government or the healthcare
system, and high rates of concern that the development of the
vaccine did not take their needs into account. These surveys reported that for the BIPOC communities, confidence in vaccine
safety and effectiveness were the number one predictor of vaccine intention. Thus, critical trust-building efforts must focus
on healthcare institutions and professionals establishing their
trustworthiness, by ensuring that communities have access to
high-quality information that increases their understanding
of the science behind vaccine development and mechanisms.
These efforts must also consider the historical trauma and
distrust of vaccinations, the government, and the healthcare
system borne by BIPOC communities [40]. Reduced vaccine
confidence within BIPOC communities must be appreciated
within the extended historical context that has engendered contemporaneous and historical mistrust of health systems. Such
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wounds that persist today [10]. The propagation of beliefs reifying race as a biological factor can have devastating outcomes
for minoritized people [11]. Black, Hispanic, American Indian/
Alaska Native, and Native Hawaiian/Pacific Islander patients
receive lower-quality care than white patients for 30%–40%
of quality measures assessed by the Agency for Healthcare
Research and Quality [12]. Although there have been steps
taken to address historical wrongdoing, chronic underfunding
and underresourcing of healthcare institutions primarily caring
for minoritized communities limit the longevity of these gains.
For example, the majority of AI/AN obtain care through a fragmented system dominated by the IHS, a chronically underfunded federal agency that suffers from a widespread shortage
of providers [13]. As a result, healthcare facilities serving this
population may be at greater risk of being overwhelmed by the
crisis than other US clinical facilities.
Furthermore, there is a dearth of healthcare professionals
from BIPOC communities [14] and significant gaps in pay, advancement, and opportunity [15]. Most importantly, patient
care is impacted by the lack of cultural diversity among healthcare professionals. For example, studies have demonstrated that
Black patients experience poorer quality of communication and
reduced shared decision-making compared with white patients,
and racial concordance is clearly associated with better communication [16]. Therefore, racially concordant public health
messaging can have a significant impact in establishing trust in
healthcare entities among BIPOC communities [17].
Consequently, the combination of historical events and contemporaneous inequities impacting BIPOC people attributed to
structural racism has justifiably rendered healthcare institutions
untrustworthy in the eyes of minoritized people. Herein lies the
challenge faced during this pandemic where we now have vaccines proven effective at preventing severe disease and death:
BIPOC communities are experiencing the worst morbidity and
mortality of COVID-19 [18–25] yet Black and Hispanic populations are some of the least vaccinated groups in the United
States [26–28].
An approach to increasing vaccine confidence and uptake
in BIPOC communities must be creative, flexible, and nimble,
addressing the heterogeneous concerns and barriers to vaccine
access that people may have. In this study, we describe the nuances of vaccine confidence in BIPOC communities, explore
issues with vaccine access, and suggest that BIPOC healthcare
professionals are well positioned to provide insight into promoting vaccine uptake in minoritized populations.

historically informed mistrust of medical and public health systems remains coupled to known disparities in quality-of-care
delivery experienced by BIPOC communities through today,
undergirding skepticism of health systems and structures for
even those with the highest health literacy in these communities.

Although white workers represent the majority of the overall
healthcare workforce (64%), Black and Hispanic workers are
more heavily concentrated in Healthcare Support and Personal
Care and Services sectors [42]. The Centers for Disease Control
and Prevention reported 412 091 cases of COVID-19 and
1463 COVID-19 deaths among healthcare personnel (HCP) in
the United States as of February 26, 2021 [42, 43]. Data from
February to July 2020 showed that, among HCP COVID-19
cases, healthcare support workers accounted for the largest proportion within the HCP group (32%) [44]. For HCP who are
members of historically disenfranchised racial/ethnic groups,
decisions regarding the COVID vaccine are influenced by their
professional backgrounds, historical context, and more recent
experiences of differential treatment in the public sphere and
the workplace [45, 46]. They may wrestle with whether to (1)
advocate for vaccines as a major component of the strategy
against a condition that has had a devastatingly disproportionate impact on their communities or to (2) maintain skepticism, reservation, and protection of themselves and their
communities against new vaccine tools in the face of mistrust
engendered by this embedded historical experience [47, 48].
This issue is particularly challenging because some data suggest
BIPOC healthcare providers may hold particularly heightened
sway in influencing the decision of BIPOC community members to obtain a COVID-19 vaccine [40, 41].
Efforts to promote equitable vaccine uptake for these HCP
will therefore need to address these complexities. In a confidential survey conducted in 2 large hospitals at the end of 2020,
concern about side-effects and not knowing enough about the
vaccine were among the most common reasons (89.1% and
77.9%, respectively) that employees indicated for not being
willing to take a COVID-19 vaccine [49]. Only 29.7% of Black
and 54.4% of Hispanic hospital employees in that study were
planning to receive a COVID-19 vaccine, compared with 69.5%
of white and 74.1% of Asian employees [49]. Information about
COVID-19 vaccines provided to HCP should include accurate
research findings and the details of the vaccine approval process
to help answer questions about safety and efficacy for individuals with a broad range of scientific knowledge, including HCP
who work in nonclinical roles [45]. Healthcare personnel who
are members of BIPOC communities may also witness and experience discriminatory practices in the settings in which they
work that reinforce concerns that they may not be treated fairly,
despite working within the healthcare system. Strategies aiming

NUANCES OF ADDRESSING VACCINE CONFIDENCE
AMONG IMMIGRANT AND REFUGEE COMMUNITIES

Immigration from countries and communities in every continent over many centuries has been the defining event underlying the creation of an increasingly diverse population in the
United States. Attitudes towards vaccination may be not sufficiently granular to account for the myriad of socioeconomic,
cultural, religious, and other factors that could inform considerations for addressing vaccine confidence and uptake in these
disparate communities. In addition to the harmful effects of social determinants of health and systemic racism experienced by
US-born BIPOC, immigrant and refugee populations experience the compounded impact of anti-immigration policies and
rhetoric, language barriers, health illiteracy, and unfamiliarity
with navigating the US healthcare system [50, 51]. It is common
for immigrants and refugees to maintain social media contact
with family and friends in their country of origin, compounding
an infodemic (ie, overabundance of rapidly spreading information, some accurate and some inaccurate, making it difficult to
identify trustworthy information sources) of misinformation
through which they must navigate. The dominant narrative
around the COVID-19 vaccine in other countries frequently
differs from that in the United States. Therefore, educational
programs that target dominant messages in US social media
may not influence vaccine confidence in these populations. It
is imperative that US public health officials leverage existing
immigrant and refugee community organizations to better
understand the infodemics affecting immigrant and refugee
populations. We must pursue tailored education campaigns
based on in-depth analysis of norms, beliefs, misinformation,
and preconceived notions prevalent in any given community
that may be culturally or geographically distinct. The pandemic
has fueled an intense increase in nationalism with calls initially to prioritize vaccines for residents and citizens ahead of
undocumented immigrants. However, this position is contrary
to the urgent public health need to vaccinate as many people
as possible, particularly when immigrants, including undocumented immigrants, comprise a large constituency of essential
workers at highest risk for COVID-19 [52]. Therefore, although
it is important to remove language barriers to vaccination efforts, equally important are efforts to remove barriers related
to immigration status, such as requiring proof of residency or
citizenship, or insurance status, and explicitly communicate to
these populations that they will not be turned away or reported
if they present themselves for a vaccine appointment [53].
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VACCINE CONFIDENCE AMONG BIPOC
HEALTHCARE PERSONNEL

to improve vaccine confidence among BIPOC HCP need to
acknowledge and address this mistrust of the medical system
to be effective [41]. Approaches must include culturally appropriate messaging that acknowledges that their experiences as
healthcare workers and healthcare consumers may differ from
those of their white counterparts.

THE RIGHT COMMUNICATION STRATEGY

4 • ofid • Marcelin et al

The importance of trusted messengers in the allocation and
distribution strategy cannot be overstated. Trusted messengers
in these communities may not include traditional healthcare
professionals, due to the historical underpinnings with prior
unethical experimentation in this population. Faith or community leaders and other influential persons may be viewed as
trusted messengers in the BIPOC population. They should be
an integral part of activities designed to engage, educate, and
ultimately positively influence prospective vaccine recipients
(Figure 1). More importantly, this collaboration should incorporate empathic listening and cocreation of solutions with the
community leaders based on their needs, rather than bringing
predetermined solutions without their involvement [55]. A university hospital in California implemented a 3-tiered approach
to engage the community in a vaccination strategy [56]. They
began with the direct empowerment of local faith leaders
through a COVID-19 faith summit, after which the pastors
themselves coordinated information sessions about vaccines to
their congregations. The faith leaders helped members make
appointments and register using paper forms to avoid a technology barrier, and, finally, the mobile vaccine clinics themselves were held on church grounds [56]. Although the AI/AN
community experience multiple underlying systemic inequities
possibly creating barriers to vaccination, tribal autonomy with
design and implementation of vaccine distribution efforts has
contributed to higher vaccination rates among tribal citizens
compared with other racial groups [36]. For example, in the
Navajo Nation, traditional healers were instrumental in leading
the way with COVID-19 vaccine messaging by choosing to
be vaccinated first in the community, along with healthcare
workers, President Jonathan Nez, and other community leaders.
The transparent, coordinated strategy [57, 58] emphasized
clear, unified messaging in both English and Navajo languages,
and it included utilization of digital and social media channels,
all of which influenced increased uptake of vaccines in this
community.
Although many trusted messengers may come from outside
of the healthcare workforce, vaccine confidence can certainly
be influenced by having ethnically diverse healthcare workers
with good rapport with their communities engage in frequent
open and transparent dialogues to address people’s questions
[41]. Concerns and ambivalence toward the vaccine should be
addressed and welcomed in a nonjudgmental manner with a
bidirectional discussion opportunity. The BIPOC healthcare
professionals lead many of the outreach programs or personal
engagement mentioned in this article [45–48, 53, 56]; healthcare organizations should leverage this work that is already
being done by partnering with BIPOC healthcare professionals
to provide them with the resources they need to amplify their
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Well conceived and appropriately designed background research on the addressable and actionable factors influencing
vaccine confidence should initially be conducted. Differences
in vaccine acceptance rates vary across demographics based on
multiple factors, including age, ethnicity, socioeconomic status,
geographic location, and source of information. Therefore, we
must use multifaceted approaches to build vaccine confidence
in ethnically diverse communities, focusing on both the delivered messages and the messengers.
A practical communication approach requires public health
officials and HCP to earn the community’s trust through cultural humility, transparency, and open-mindedness. First, a
nonprescriptive, bidirectional listening and learning approach
should be adopted, sharing respect for and empathy with cultural beliefs and norms within these communities. When possible, partnerships with trusted community resources such as
faith-based leaders, community organizers, and community
mentors should be emphasized to have a multipronged approach. Second, we must recognize our knowledge gaps in
the pandemic’s trajectory and the COVID-19 vaccine trial results. Third, we should empathize with our audience, respect
their opinions, and understand the impact of social injustice,
health inequities, and systemic racism in healthcare on people’s
attitudes. A condescending or dismissive approach will be ineffective, particularly in the context of conspiracy theories or
misinformation that are often prevalent and significantly influence attitudes about vaccination. Public health officials and
healthcare professionals should openly address past and ongoing injustices with empathy and reassurance based on scientific evidence.
We may encounter individuals with varying levels of ambivalence influencing their likelihood of accepting vaccines
after hearing our messages (Table 1). Sentiments toward
COVID-19 vaccines may include “resistance” due to firmly
held beliefs; “misinformation” by way of myths or inappropriate messages; a “wait and see” approach to gather more
information before committing; or “acceptance” and willingness to confirm and share experiences with others. It is
important to note that these sentiments do not represent a
linear progression. Individuals may experience bidirectional
transition between these feelings depending on personal experience and societal input, and they should be given space
(and grace) to change their minds. Table 1 illustrates our
proposed strategic approach to a shared discussion about deliberation with individuals experiencing these 4 sentiments
toward COVID-19 vaccines. Our messages should be flexible
to probe our patients’ position, to accommodate dynamic
groups of constituents, and to focus on specific concerns that
shape their attitudes toward COVID-19 vaccine acceptance,
with an overarching goal to helping to make informed decisions about vaccine choices [54].

IMPORTANCE OF INCLUDING TRUSTED
MESSENGERS IN THE ALLOCATION, DISTRIBUTION,
AND COMMUNICATION STRATEGY

Table 1.

Four Sentiments Toward Coronavirus Disease 2019 (COVID-19) Vaccines and Approach to Shared Discussion and Deliberation
Likelihood of
Vaccine Acceptance

Sentiment

Definition

Major Concerns

Resistance

Firmly held beliefs

Speed of vaccine production
and approval
Previous vaccine adverse
experiences
Vaccine not seen as a high
priority
Feeling marginalized
Doubts legitimacy of COVID19 pandemic

Low

Clarify prior scientific work on vaccine technology,
with pooled scientific and financial resources
leading to successful vaccine development
Reassure that data and safety monitoring procedures were followed in all stages of development
and approval
Ensure participation of community representatives
in the Emergency Use Authorization process
Advocate for long-term public health and socioeconomic plan
Use culturally competent tools for outreach
Engage local community and faith leaders as
trusted messengers

Misinformation

Influenced by widespread
myths, misconceptions, and
falsehoods

Trust the wrong messengers
Reliance on the internet and
social media for healthrelated information
Political bias

Low-medium

Identify and educate trusted messengers
Clarify scientific data and send consistent messages
Use the internet and social media to spread accurate information
Stick to the facts: avoid partisan arguments or associating vaccination with specific politicians

Wait and see
approach

Want to watch vaccine recipients’ experiences
Searching for more scientific
data and trusted messengers
Gathering more information
before committing

Unsure about vaccine safety
and efficacy
Insufficient mid- and longterm data
Personal health issues

Medium-high

Respect individual choices
Acquiesce vaccine questions
Highlight limitations of current scientific knowledge
Underline scientific consensus
Express willingness to update information and
accept changes

Acceptance

Feel comfortable with information about the vaccine and
ready to receive it

May have moved through
any or all of the previous 3
sentiments

High

Encourage willingness to confirm and share their
experiences with their community as trusted
messengers

many BIPOC. An analysis of community health center COVID19 vaccinations across the country reported that over 50% of
people receiving both doses of their vaccines were BIPOC, with
vaccination rates exceeding the national rates [60].
VACCINE ACCESS

Notwithstanding the justifiable deliberations that BIPOC communities may experience regarding COVID-19 acceptance,
the discussion about inequitable vaccine uptake must include
1 additional important component: access to vaccines. The
Advisory Committee on Immunization Practices suggested a
phased vaccine rollout plan because it was apparent that the
demand for COVID-19 vaccines would exceed supply during
the first months of the national COVID-19 vaccination program, preventing everyone from being able to get vaccinated
at the same time [61]. This approach is helpful; however, although the Federal recommendations for prioritizing of individuals for vaccination accounted for mitigation of risk for
older adults and those with specific comorbidities, decisions on
how prioritization occurred in practice were left to the states.
The National Academy of Sciences suggests that any framework
for equitable distribution should “explicitly address the higher
burden of COVID-19 experienced by the populations affected
most heavily, given their exposure and compounding health inequities”, and it recommended that across all priority groups,
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messages and increase their reach into BIPOC communities.
However, although BIPOC healthcare professionals need more
significant elevation in these efforts, the burden does not fall
solely on their shoulders, mainly because there are so few of
them. Hospitals and professional medical societies should develop public-facing resources that acknowledge concerns and
answer questions pertinent to BIPOC communities (Figure 1).
These resources should be easily accessible, use language that
is easy to understand, and be available in multiple formats for
different learning styles.
Although it is important to engage faith, community leaders,
and BIPOC healthcare professionals as trusted messengers in
vaccine uptake strategies, we acknowledge that an approach that
engages only these leaders is not feasible. Receiving COVID-19
vaccine information from healthcare professionals with whom
individuals already have an established patient care relationship
may have utility in increasing vaccine trust among BIPOC individuals [59]; therefore, more efforts to place vaccines in primary
care offices is important. Similarly, another important trusted
source may be community health centers. These locations are
uniquely positioned within the communities to ensure communication with people who may have questions or concerns about
vaccines. Community health centers provide primary care services to many individuals experiencing homelessness or living
in low-income housing and rural neighborhoods, including

Approach

Strategies to increase vaccine uptake within minoritized communities
An approach to increasing vaccine confidence and uptake in BIPOC communities must be creative, flexible, and
nimble, addressing the heterogeneous concerns and barriers to vaccine access people may have.

Paper registration
Allow walk-up visits
Say vaccine is FREE!

Mobile clinics
Pop-up clinics
Home-visits

Reassure
confidentiality of
immigrant status

Engage community
leaders

Trusted faith
leaders

Trusted community
members

Trusted traditional
healers

Use existing local
media; radio, town
halls, etc.

Consider cultural/
language needs
Leverage BIPOC HCP

Allow people to ask
questions
Answer questions
transparently

Medical professional
orgs e.g., IDSA, HIVMA,
SIDP

Provide financial,
personnel, intellectual
resources

Advocate strongly for
equitable distribution

Customize vaccine
education
Leverage
professional
organizations
@DrJRMarcelin

BIPOC; Black, Indigenous, and People of Color. HCP; Healthcare Professionals. IDSA; Infectious Diseases Society of America.
HIVMA; HIV Medicine Association. SIDP; Society for Infectious Diseases Pharmacists.

Figure 1. Strategies to increase vaccine uptake within minoritized communities. BIPOC, Black, Indigenous, and People of Color; HIVMA, HIV Medicine Association; IDSA,
Infectious Diseases Society of America; SIDP, Society of Infectious Diseases Pharmacists.

there should be an accounting for prioritization of those with
higher structural vulnerability [33]. An evaluation of these
state-directed practices demonstrated that in many cases, the
states deprioritized certain groups such as essential workers,
who are predominantly BIPOC individuals, and often ignored
other groups such as American Indian/Alaska Native populations or those living in low-income housing [62]. Furthermore,
the reliance of vaccine appointments on electronic scheduling
creates another hindrance to people without reliable access
to technology [63]. The development of this information in
English only serves as a barrier to individuals whose primary
communication language is different [64].
The positive impact of intentional, directed vaccine access is apparent in the story of the Navajo Nation, despite the
American Indian/Alaska Native community experiencing some
of the worst morbidity and mortality from COVID-19 [5]. As of
April 5, 2021, IHS had received more than 1.5 million COVID19 vaccine doses, translating to approximately 75 000 doses per
100 000 people served, one of the highest rates of vaccine delivery nationwide compared with state vaccination programs
[36]. A coordinated effort among the IHS, Navajo Nation,
and tribal health organizations organized a streamlined vaccine rollout with lowered age administration priority groups,
centralized vaccine delivery, and mass walk-in vaccination
efforts that resulted in almost 50% of the Navajo population
receiving their first vaccine dose [57, 58]. However, the experience in the tribal community may not reflect that of the 78%
of the American Indian/Alaska Native community who reside
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in urban populations outside of tribal lands [65], and similarly
BIPOC outside of a system such as this with a focused effort toward vaccination may experience many barriers to vaccination,
including language, distance, and lack of culturally appropriate
information. In these situations, the approach to equitable uptake in these populations should remove these barriers by emphasizing language and culturally congruent messaging, with
flexible and convenient vaccination opportunities such as
pop-up clinics or home vaccinations (Figure 1).
CONCLUSIONS

Coronavirus disease 2019 has unveiled for the world something
that BIPOC living in America have endured for centuries; that
they are at the highest risk of inequitable care and subsequent
devastating health disparities. Because we consider vaccines as
a vehicle for ending this pandemic, our only successful move
forward ensures that the communities most impacted are protected. Vaccine confidence can be strengthened if we begin with
respect and transparency and if our approaches to vaccine allocation, distribution, and messaging start and end with an equitable lens. Therefore, the approach to COVID-19 vaccines in
BIPOC must focus on equity instead of hesitancy.
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